GSK to name Dr Vishal Sikka as non-executive director Ruchika Sharma6 May 2022 1:24 PM ISTNew Delhi: GlaxoSmithKline has announced that Dr Vishal Sikka, founder and CEO of Vianai Systems, will join the Board of the Company as a...
Health Bulletin 27/April/2022 Dr. Nandita Mohan27 April 2022 4:58 PM ISTHere are the top health stories for the day :NMC denies permission to 3 Medical Colleges, 550 MBBS seats lostFinding major deficiencies in three major...
GSK launches single inhaler-triple therapy Trelegy Ellipta to treat COPD in India Ruchika Sharma27 April 2022 11:53 AM ISTTrelegy is delivered via the innovative Ellipta inhaler that provides accurate dosing through its consistent dose delivery mechanism and is associated...
Bayer appoints Tara Frenkl as new head of oncology development at oncology strategic business unit Ruchika Sharma24 April 2022 11:30 AM ISTBerlin: Bayer has announced Tara Frenkl, MD, MPH as the new Head of Oncology Development at its Oncology Strategic Business Unit, effective April 25,...
GSK- CureVac experimental COVID variant vaccine effective in mice study Ruchika Sharma24 April 2022 9:15 AM ISTFrankfurt: CureVac and GSK's second-generation vaccine candidate targeting two recent COVID-19 variants has been shown to be highly...
GSK Daprodustat bags USFDA review to treat anemia of CKD Ruchika Sharma20 April 2022 11:44 AM ISTDaprodustat, a HIF-PHI, belongs to a novel class of oral medicines indicated for the potential treatment of anemia of CKD in adult patients not on...
GSK to acquire Sierra Oncology for USD 1.9 billion Ruchika Sharma17 April 2022 11:00 AM ISTUnder the terms of the agreement, the acquisition will be effected through a one-step merger in which the shares of Sierra Oncology outstanding will...
GSK-Vir COVID therapy Sotrovimab authorization junked by USFDA Roshni Dhar8 April 2022 11:17 AM ISTThe U.S. health regulator said on Tuesday GlaxoSmithKline and Vir Biotechnology's antibody therapy was no longer authorized as a COVID-19 treatment,...
USFDA junks authorization of GSK- Vir COVID therapy Sotrovimab Ruchika Sharma6 April 2022 4:20 PM ISTSotrovimab is no longer authorized to treat COVID-19 in any US region due to increases in the proportion of COVID-19 cases caused by the Omicron BA.2...
GSK announces appointment of six directors to Designate Haleon Board MD Bureau17 March 2022 12:43 PM ISTGlaxoSmithKline plc today announced the appointment of six directors to the designate Board of Haleon, the new independent company to be formed...
No USFDA approval for AstraZeneca's treatment for chronic nasal condition MD Bureau15 March 2022 3:02 PM ISTThe London-listed drugmaker said the U.S. Food and Drug Administration (FDA) had issued a complete response letter following AstraZeneca's application...
GSK Consumer Healthcare to go independent, called Haleon MD Bureau25 Feb 2022 12:42 PM ISTNew Delhi: GlaxoSmithKline plc (GSK) has announced that the new company, to result from the proposed demerger of Consumer Healthcare from GSK in...
